ACG guidelines classification scheme: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) No edit summary |
Tarek Nafee (talk | contribs) |
||
Line 5: | Line 5: | ||
==Classification of Recommendation== | ==Classification of Recommendation== | ||
'''GRADE system of quality of evidence and strength of recommendation:'''<ref name="pmid23896955">{{cite journal| author=Tenner S, Baillie J, DeWitt J, Vege SS, American College of Gastroenterology| title=American College of Gastroenterology guideline: management of acute pancreatitis. | journal=Am J Gastroenterol | year= 2013 | volume= 108 | issue= 9 | pages= 1400-15; 1416 | pmid=23896955 | doi=10.1038/ajg.2013.218 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23896955 }} </ref> | |||
=== '''GRADE system of quality of evidence and strength of recommendation:'''<ref name="pmid23896955">{{cite journal| author=Tenner S, Baillie J, DeWitt J, Vege SS, American College of Gastroenterology| title=American College of Gastroenterology guideline: management of acute pancreatitis. | journal=Am J Gastroenterol | year= 2013 | volume= 108 | issue= 9 | pages= 1400-15; 1416 | pmid=23896955 | doi=10.1038/ajg.2013.218 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23896955 }} </ref> === | |||
'''Quality of Evidence''' | |||
{| class="wikitable" | {| class="wikitable" | ||
!GRADE | !GRADE | ||
Line 21: | Line 23: | ||
|Very Low | |Very Low | ||
|Any estimate of the effect is very uncertain. | |Any estimate of the effect is very uncertain. | ||
|} | |||
'''Strength of Recommendation''' | |||
The strength of recommendation is determined based on a benefit vs. cost/risk to patient. | |||
{| class="wikitable" | |||
!GRADE | |||
!Explanation | |||
|- | |||
|Strong | |||
|The desirable effects of an intervention clearly outweigh the undesirable effects or clearly do not. | |||
|- | |||
|Moderate | |||
|The benefit to the patient | |||
|- | |||
|Weak/Conditional/Discretionary | |||
|The trade offs are less certain between the desirable and undesirable effects of an intervention. | |||
|} | |} | ||
Revision as of 20:04, 30 November 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Tarek Nafee, M.D. [2]
Overview
The GRADE system of quality of evidence and strength of recommendation gives insight into the confidence of the American College of Gastroenterology in the recommendation and the likelihood that further research would change said recommendation.[1]
Classification of Recommendation
GRADE system of quality of evidence and strength of recommendation:[1]
Quality of Evidence
GRADE | Explanation |
---|---|
High | Further research is very unlikely to change our confidence in the estimate of effect. |
Moderate | Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. |
Low | Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. |
Very Low | Any estimate of the effect is very uncertain. |
Strength of Recommendation
The strength of recommendation is determined based on a benefit vs. cost/risk to patient.
GRADE | Explanation |
---|---|
Strong | The desirable effects of an intervention clearly outweigh the undesirable effects or clearly do not. |
Moderate | The benefit to the patient |
Weak/Conditional/Discretionary | The trade offs are less certain between the desirable and undesirable effects of an intervention. |
References
- ↑ 1.0 1.1 Tenner S, Baillie J, DeWitt J, Vege SS, American College of Gastroenterology (2013). "American College of Gastroenterology guideline: management of acute pancreatitis". Am J Gastroenterol. 108 (9): 1400–15, 1416. doi:10.1038/ajg.2013.218. PMID 23896955.